M&A Deal Summary

Roche Acquires Ventana Medical Systems

On January 22, 2008, Roche acquired medical products company Ventana Medical Systems for 3.4B USD

Acquisition Highlights
  • This is Roche’s 2nd transaction in the Medical Products sector.
  • This is Roche’s 6th largest (disclosed) transaction.
  • This is Roche’s 4th transaction in the United States.
  • This is Roche’s 1st transaction in Arizona.

M&A Deal Summary
Date 2008-01-22
Target Ventana Medical Systems
Sector Medical Products
Buyer(s) Roche
Deal Type Add-on Acquisition
Deal Value 3.4B USD
Advisor(s) Goldman Sachs (Financial)
Sidley (Legal)

Target

Ventana Medical Systems

Tucson, Arizona, United States
Ventana develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. The company's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Roche

Basel, Switzerland
Category Company
Founded 1896
Sector Life Science
Employees100,920
Revenue 60.4B CHF (2023)
DESCRIPTION
Roche's corporate headquarters in Basel, Switzerland.
Roche's corporate headquarters in Basel, Switzerland.

Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.

DEAL STATS #
Overall 7 of 42
Sector (Medical Products) 2 of 5
Type (Add-on Acquisition) 6 of 35
State (Arizona) 1 of 1
Country (United States) 4 of 28
Year (2008) 1 of 3
Size (of disclosed) 6 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-26 BioVeris

Gaithersburg, Maryland, United States

BioVeris Corporation is a health care and biosecurity company developing proprietary technologies in diagnostics and vaccinology. The Company is dedicated to the development and commercialization of innovative products and services for healthcare providers, their patients and their communities. BioVeris is headquartered in Gaithersburg, Maryland (USA).

Buy $600M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-04-15 Piramed Limited

Slough, United Kingdom

Piramed is a biotech company whose mission is to discover and develop new medicines primarily for the treatment of cancer and immune inflammatory disorders such as arthritis and asthma. Piramed is a leading company in the discovery of highly selective drugs that inhibit different isoforms of PI3-K, enzymes that are increasingly recognised as key players in a wide variety of disease processes.

Buy $160M
Mergr

Product

Company

Legal